Immunostaining experiments performed in PC-3U prostate cancer cells and KELLY neuroblastoma cells revealed that TβRI co-localized with AURKB in the midzone, as well as in the midbody (Figure 2a-b). The gene discussed is TGFBR1; the disease is neuroblastoma.